XLXiaona Li

Xiaona Li

*This is an algorithmically generated author record based on publicly available information.

Xiaona Li has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Equivalent of Carbon Dioxide at the Anaerobic Threshold Predicts Acute Exacerbations in Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study

    by Yunxiao Li, Xiaona Li, Fang Lin, Xing Hu, Siqi Liu, Mengmeng Qiu, Jianxiong Zhang, Ranran Zhao, Shan Nie, Bo Xu, et al.

    To investigate the predictive value of the equivalent of carbon dioxide at the anaerobic threshold (EqCO2@AT) for acute exacerbations (AE) in patients with chronic obstructive pulmonary disease (COPD). This retrospective cohort study included 79 patients with COPD who underwent baseline pulmonary function testing and cardiopulmonary exercise testing (CPET). EqCO2@AT = 30 was used only as an empirical threshold for descriptive stratification, rather than as an outcome-derived cutoff. Patients were also classified into non-AE and AE groups according to annualized exacerbation frequency. Baseline characteristics, pulmonary function, and CPET parameters were compared between groups. Logistic regression was used to evaluate the association between EqCO2@AT and AE risk. Predictive performance was assessed using receiver operating characteristic curves, calibration analysis, decision curve analysis, Kaplan–Meier analysis, and a simplified nomogram. Of the 79 patients, 16 were classified into the low EqCO2@AT group and 63 into the high EqCO2@AT group. Patients with higher EqCO2@AT were older, had lower BMI, greater smoking exposure, lower FEV1% predicted and DLCO% predicted, reduced exercise capacity, and higher ventilatory inefficiency parameters. Compared with the non-AE group, the AE group had worse lung function, lower exercise capacity, and higher VE/VCO2 slope and EqCO2@AT. EqCO2@AT was associated with AE risk in univariable analysis (OR 1.122, 95% CI 1.027–1.226, P = 0.011) and remained significant after adjustment for age, BMI, and FEV1% predicted (OR 1.269, 95% CI 1.110–1.450, P < 0.001). The AUC of EqCO2@AT alone was 0.739, whereas the combined model achieved an AUC of 0.850. Kaplan–Meier analysis showed significantly lower AE-free survival in the high EqCO2@AT group (log-rank P = 0.002). The simplified nomogram provided an individualized visual tool for AE risk estimation. Elevated EqCO2@AT is associated with impaired ventilatory efficiency, reduced exercise capacity, and increased AE risk in COPD. A model incorporating EqCO2@AT, age, BMI, and FEV1% predicted showed good predictive performance and may support individualized AE risk stratification. These findings suggest that CPET-derived ventilatory efficiency parameters may provide clinically useful information beyond conventional pulmonary function assessment, although validation in larger multicenter prospective cohorts is still required.

  • Open Access

    VE-VCO2 Slope During Cardiopulmonary Exercise Test Predicts Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study

    by Xiaona Li, Fang Lin, Jingxuan Wu, Jianxiong Zhang, Siqi Liu, Mengmeng Qiu, Wei Yuan, Shan Nie, Fugui Yan, Bo Xu, et al.

    Cardiopulmonary Exercise Test (CPET) serves as an integrative assessment tool to evaluate cardiac function, respiratory responses, and neuromuscular capacity in patients with chronic obstructive pulmonary disease (COPD) during incremental cycling exercise. VE-VCO2 slope during CPET was not fully understood in predicting acute exacerbations of COPD (AECOPD). This study aims to establish a predictive model for AECOPD based on the VE-VCO2 slope. In total, 79 patients with COPD were recruited between 2013 and 2019. All participants underwent baseline pulmonary function tests and CPET and were followed up for 5 years thereafter. Independent two-sample t-tests and Chi-square tests were used to compare AECOPD and Non-AECOPD groups. Univariate and multivariate Cox regression analyses were utilized to identify predictive factors for AECOPD. The diagnostic performance of these variables was evaluated by receiver operating characteristic (ROC) curve analysis. The optimal cutoff values calculated by Youden’s index. Kaplan-Meier survival analysis between subgroups was based on the optimal cutoff values. Generating Forest plots to visualize Cox regression analysis results. The AECOPD group contains 62 participants and the Non-AECOPD group contains 17 participants. Groups comparisons revealed significant differences in VE-VCO2 slope, age, BMI, FEV1%predicted, FEV1/FVC ratio, and EqCO2. Multivariate Cox regression analysis identified VE-VCO2 slope (OR = 1.19, 95% CI: 1.09–1.29, p < 0.001), age (OR = 1.05, 95% CI: 1.02–1.09, p = 0.005), and FEV1%predicted (OR = 0.96, 95% CI : 0.94–0.99, p = 0.015) as significant predictors of AECOPD. The ROC curve analysis results about the above predictors found that the AUC of VE-VCO2 slope is highest independently in 1 year, 3 years and 5 years, with the optimal cutoff values = 28.42 in 5 years (hazard ratio = 3.18, 95% CI: 1.639–6.2, p < 0.001). The stratification of VE-VCO2 slope ≥28.42 was an independent predictor of AECOPD. Our study established VE-VCO2 slope as a novel stratified clinical biomarker for predicting AECOPD.